Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the coming months [5]. Core Insights - The company is expected to achieve a net profit of 60-66 million yuan in 2025, representing a year-on-year growth of 40.0-54.0%. The fourth quarter alone is projected to see a net profit of 11.94-17.94 million yuan, with a significant year-on-year increase of 154.7-282.7% [5]. - Demand recovery across various application fields is driving simultaneous growth in revenue and profit. The market demand is returning to normal levels, particularly in the cultivation substrate sector, while the nutritional food sector benefits from ongoing market recovery [5]. - Cost structure optimization is contributing positively to profit margins, with a reduction in certain expenses, including employee stock incentive costs and impairment provisions, easing cost pressures [5]. - The company is expanding its overseas presence by establishing subsidiaries in the Netherlands and the United States, aiming to tap into the overseas raw material market and address capacity shortages in other sectors [5]. Financial Data and Profit Forecast - Total revenue is projected to grow from 404 million yuan in 2025 to 622 million yuan in 2027, with year-on-year growth rates of 19.2%, 25.3%, and 22.9% respectively [4]. - The net profit forecast for 2025 is 63 million yuan, increasing to 108 million yuan by 2027, with corresponding growth rates of 47.3%, 32.2%, and 29.6% [4]. - Earnings per share are expected to rise from 0.81 yuan in 2025 to 1.39 yuan in 2027, reflecting the company's improving profitability [4].
无锡晶海（920547）：业绩符合预期，25年需求回暖+成本优化，看好26年海外拓展：无锡晶海（920547）：